Molecular subgroup analyses have further shown heterogeneity among OM patients, where distinct immune infiltration patterns and osteoclast-related pathways (e.g., CTSK) correlated with disease severity and length of hospital stay (31). The gene discussed is CTSK; the disease is ocular melanoma.